Today: 27 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow shares traded at $156.25 as of 17:00 UTC, up 0.6% after a 5-for-1 stock split took effect Dec. 18. The company completed its acquisition of Moveworks and is in reported talks to buy cybersecurity firm Armis for up to $7 billion. Shares fell over 11% on Dec. 15 after the Armis news surfaced. Analyst concerns focus on deal size and growth strategy.
22 December 2025
·
Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs shares traded near $903 by midday Monday, within 2% of their 52-week high, after a year of strong gains driven by robust dealmaking and client activity. Reuters data shows Goldman led investment banking fees in EMEA in 2025 with a 6.8% share. The bank’s next earnings report is due January 15, 2026. Analyst price targets remain below current stock levels.
22 December 2025
·
Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard shares rose 0.8% to $576.90 on Dec. 22 after Fiserv expanded its partnership with the company to scale AI-driven “agentic commerce” for merchants. Mastercard also announced a new B2B payments launch with First Abu Dhabi Bank and a 14% dividend increase with a $14 billion buyback. Fee-related litigation and regulation remain in focus.
22 December 2025
AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie shares traded at $227.73 midday Monday, near recent highs, as the company remains one of three major drugmakers not signed onto the White House’s new “most-favored-nation” drug-pricing agreements announced December 19. Investors are watching for AbbVie’s next move on the policy front, while its core immunology drugs and dividend growth continue to anchor fundamentals.
22 December 2025
···
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen shares rose to around $331 on December 22, 2025, after the White House announced drug-pricing deals with major drugmakers, including Amgen. The company will offer Aimovig and Amjevita at $299 per month through direct-to-patient sales. Analysts said the agreements may ease tariff and political risks but are unlikely to significantly affect pharma profits in the near term.
22 December 2025
··
Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot shares traded around $347 Monday afternoon, up 0.7% for the day, as investors weighed new analyst commentary and 2026 outlooks. Wolfe Research nudged its price target to $415 and reiterated an Outperform rating. The stock remains down about 10% to 11% year-to-date, lagging the broader market. Trading volume and price range stayed steady, with no major corporate news.
22 December 2025
·
Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals joined the Nasdaq-100 Index on Dec. 22, 2025, as the annual reconstitution took effect before the market opened. Shares traded near $405.60, up 1.3% from the prior close. The company recently announced a $250 million U.S. manufacturing expansion and reported strong adoption of its AMVUTTRA therapy for transthyretin amyloidosis.
22 December 2025
···
Johnson & Johnson Stock (JNJ) News Today: Latest Updates, Analyst Forecasts, and What Could Move Shares Next (Dec. 22, 2025)

Johnson & Johnson Stock (JNJ) News Today: Latest Updates, Analyst Forecasts, and What Could Move Shares Next (Dec. 22, 2025)

Johnson & Johnson shares traded at $206.63 Monday after the European Commission approved TREMFYA for pediatric psoriasis, marking its first IL-23 inhibitor indication in children. The company also secured recent FDA approvals for RYBREVANT FASPRO in lung cancer and TRUFILL n-BCA for chronic subdural hematoma. Ongoing talc litigation continues to affect investor sentiment.
22 December 2025
·
Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems joined the Nasdaq-100 Index before the market opened Monday, Dec. 22, 2025. Shares traded near $958.73, up 2.3% on the day, with a session range of $949.33 to $970.00. Analysts maintain a “Buy” consensus, with a 12-month average target of $1,196. The company declared a $1.56 quarterly dividend, payable Jan. 15, 2026.
22 December 2025
···
Exxon Mobil (XOM) Stock News Today: Fresh Catalysts, Analyst Forecasts, and What to Watch on December 22, 2025

Exxon Mobil (XOM) Stock News Today: Fresh Catalysts, Analyst Forecasts, and What to Watch on December 22, 2025

Exxon Mobil shares traded near $118 on Dec. 22, 2025, as investors assessed steady oil prices and the company’s updated 2030 growth plan. Exxon projects $25 billion in earnings growth and $35 billion in cash flow by 2030, with no increase in capital spending. A CFO transition is set for February 2026. Guyana and the Permian Basin remain key project areas.
22 December 2025
··
Salesforce (CRM) Stock News Today: Latest Headlines, Analyst Forecasts, and Agentforce AI Outlook (December 22, 2025)

Salesforce (CRM) Stock News Today: Latest Headlines, Analyst Forecasts, and Agentforce AI Outlook (December 22, 2025)

Salesforce shares traded near $263 on December 22, 2025, valuing the company in the mid-$200 billion range. The stock is up 14.4% over the past four weeks amid upward earnings revisions, with fiscal 2026 EPS consensus at $11.67. Q3 results showed $10.3 billion in revenue and a 35.5% non-GAAP operating margin. Investors remain focused on AI monetization and institutional positioning.
22 December 2025
··
CoreWeave Stock (NASDAQ: CRWV) News Today: DOE “Genesis Mission” Boost Meets Debt Fears, Analyst Targets, and a Make‑or‑Break 2026 Narrative (Dec. 22, 2025)

CoreWeave Stock (NASDAQ: CRWV) News Today: DOE “Genesis Mission” Boost Meets Debt Fears, Analyst Targets, and a Make‑or‑Break 2026 Narrative (Dec. 22, 2025)

CoreWeave shares climbed about 3%–4% to the mid-$80s Monday, extending Friday’s surge after news it joined the U.S. Department of Energy’s Genesis Mission. Volume topped 13 million shares by late morning. The stock remains volatile, with investors weighing government AI ties against concerns over leverage and customer concentration.
22 December 2025
·
Walmart Stock (WMT) News Today: Jefferies Target Hike, Nasdaq Shift, and 2026 Outlook to Watch (Dec. 22, 2025)

Walmart Stock (WMT) News Today: Jefferies Target Hike, Nasdaq Shift, and 2026 Outlook to Watch (Dec. 22, 2025)

Walmart shares traded at $112.98 on Dec. 22, down 1.2%, after a recent move to Nasdaq and a series of analyst price target increases. Jefferies raised its target to $132, while Truist and TD Cowen also lifted theirs. Investors are watching for Walmart’s Q4 earnings on Feb. 19, with debate intensifying over the stock’s valuation amid continued gains.
22 December 2025
·
Applied Materials Stock (AMAT) Today: Latest News, Analyst Forecasts, and 2026 Outlook as AI Chip Spending Accelerates (Dec. 22, 2025)

Applied Materials Stock (AMAT) Today: Latest News, Analyst Forecasts, and 2026 Outlook as AI Chip Spending Accelerates (Dec. 22, 2025)

Applied Materials shares rose about 1.17% to $259.40 on Dec. 22 amid a tech-led rebound and renewed AI enthusiasm. Investors weighed strong AI-driven chip demand against ongoing U.S.-China export restrictions. The Philadelphia SE Semiconductor Index also gained in early trading. Lighter holiday trading volumes heightened volatility for chip stocks.
22 December 2025
····
Lam Research Stock (LRCX) News Today: Shares Hit Fresh Highs as AI Chip Spending Lifts Forecasts Into 2026

Lam Research Stock (LRCX) News Today: Shares Hit Fresh Highs as AI Chip Spending Lifts Forecasts Into 2026

Lam Research shares surged 4.6% to $172.27 on Monday, reaching a new 52-week high of $173.58 last Friday amid heavy trading. The stock is up 138.5% year-to-date, fueled by strong AI-driven demand for semiconductor equipment and multiple price target hikes. Wall Street is watching for Lam’s next earnings, with consensus expecting $1.15 per share, up 26.4% from last year.
22 December 2025
···
1 … 574 575 576 577 578 … 755

Stock Market Today

  • WH Smith Faces Pressure as Australian Airport Retail Sales Dip Amid Middle East Conflict
    April 27, 2026, 2:46 AM EDT. WH Smith's Australian airport retail business faces mounting pressure as shares fall 15% last week, now down 16% year-to-date. The UK-listed travel retailer's cautious outlook stems from weakened passenger demand and consumer confidence linked to the Middle East conflict. Flight cuts by Qantas and Virgin disrupt revenue growth tied to aviation activity. The group reported a pre-tax loss of A$51.75 million for six months to February, widening sharply from the previous year, with dividend cuts aimed at margin protection. Australian revenue edged up to £83 million in the year to August 2024 but faces an uncertain near-term outlook due to volatile international travel flows. WH Smith projects full-year profit below last year's A$223.56 million. The company remains committed to Australia as a strategic growth market, contingent on stable global aviation recovery.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 27.04.2026

27 April 2026
LIVEMarkets rolling coverageStarted: April 27, 2026, 12:00 AM EDTUpdated: April 27, 2026, 2:52 AM EDT WH Smith Faces Pressure as Australian Airport Retail Sales Dip Amid Middle East Conflict April 27, 2026, 2:46 AM EDT. **WH Smith's Australian airport retail business** faces mounting pressure as shares fall 15% last week, now down 16% year-to-date. The UK-listed travel retailer's cautious outlook stems from **weakened passenger demand and consumer confidence** linked to the Middle East conflict. Flight cuts by Qantas and Virgin disrupt revenue growth tied to aviation activity. The group reported a pre-tax loss of A$51.75 million for six months to
Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
Go toTop